ActivX and Kyorin to Study Metabolic Disorders

genomeweb
360dx

ActivX and Kyorin to Study Metabolic Disorders

Jan 08, 2004

NEW YORK, Jan.8 (GenomeWeb News) - ActivX Biosciences and Kyorin Pharmaceutical have signed a research agreement to study compounds for metabolic disorders, Kyorin said Tuesday.

To read the full story....

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

Canon Medical Systems Acquires Majority Stake in Cancer Genomic Profiling JV
New Products Posted to GenomeWeb: Roche, Genomenon, Precipio, More
Noridian Issues Draft LCD for GenomeDx Prostate Biopsy Genomic Classifier
Predicine, Flagship Biosciences to Provide Combined Service
Study Monitors Exposure of Individuals to Airborne Biologics, Chemicals
Genomics Medicine Ireland, Academic Collaborators to Study Asthma Genetics

The Scan

The Same Genes Keep Getting Asked to Prom

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

Keep Them in the Know

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

From Tusk to Cartel

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

This Week in Nature

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Main menu